• PPD Awarded US Army RPA Develop PTSD Drugs contractpharma
    February 20, 2021
    ​PPD, Inc., a global CRO, has been awarded Defense Health Agency funds to support a five-year Research Project Award (RPA) to develop and execute an adaptive platform clinical research trial of drug interventions to treat post-traumatic stress disorder.
PharmaSources Customer Service